• Skip to primary navigation
  • Skip to main content
  • Skip to primary sidebar
  • Skip to footer
  • Email
  • Facebook
  • LinkedIn
  • Twitter
  • YouTube

International Alliance of ALS/MND Associations

  • Members' Login
  • Contact
  • Join the Alliance
  • Donate
  • Understanding ALS/MND
    • What is ALS/MND
    • Genetics
    • Diagnosis
    • Glossary
    • Navigating the Community
  • Find a Member Association
  • Support for PALS & CALS
    • Fundamental Rights for People with ALS/MND and Caregivers
    • Research
      • Clinical Trial Registry Accuracy and Maintenance in ALS/MND Research
      • Voice Preservation
      • Open Science
        • Open Label Extension
      • Expanded Access
      • Understanding ALS/MND Research
      • Improving Regulatory Pathways
      • Right to Try
      • US FDA Orphan Drug Designation
      • Unproven (Off-Label) Treatments
    • Advocacy
      • Advocacy Toolkit
      • Emergency Preparedness Toolkit
      • Equitable Access to Therapies
      • Recommendations for Trial Sponsors
    • Clinical Care
      • Genetic Counselling & Testing
      • Mental Health Support
      • Nursing and Symptom Management
      • Nutrition and Swallowing
      • Occupational Therapy and Activities of Daily Living
      • Physiotherapy and Mobility
      • Respiratory Care
      • Speech Therapy and Communication
      • Support for Family & Caregivers
      • Technology
      • Global Clinic Locator
    • Drugs in Development
      • Masitinib
      • NurOwn
      • CNM-Au8
      • ILB
      • AstroRx
      • Neuronata-R / Lenzumestrocel
      • PrimeC
      • NP001
      • Pridopidine
      • SOD1 Therapies and Trials
      • C9orf72 Therapies and Trials
      • SPG302
      • Regulatory T Cell Enhancing Therapies
      • Ulefnersen
    • Approved Drugs
      • Nuedexta
      • Radicava / Edaravone
      • Riluzole / Tiglutik
      • Rozebalamin / Methylcobalamin
      • Tofersen / Qalsody
    • Drugs No Longer in Development
      • AMX0035
      • Reldesemtiv
      • Arimoclomol
      • TUDCA
      • CuATSM
  • Support for Health Professionals
    • Breaking the News in ALS/MND
    • R.A.C.E. to Diagnose ALS/MND
  • Programs & Events
    • Calendar of Events
    • Global Day Calendar
    • Alliance Meeting
    • Allied Professionals Forum
    • “Day in the Life Of” Suite
    • Alliance Webinars
    • ALS/MND Connect
    • March of Faces
    • Patient Fellows Program
    • Alliance Fellows
    • SEED Grant Program
    • Awards
      • Forbes Norris Award
      • Humanitarian Award
      • Allied Health Professional Award
      • Student Innovation Award
  • About
    • Who We Are
    • ALS/MND Health Literacy Map
    • Board of Trustees
    • Councils, Forums & Committees
      • Scientific Advisory Council
      • PALS and CALS Advisory Council
      • Advocacy and Public Policy Forum
      • Research Directors Forum
      • Governance Committee
      • Finance Committee
    • Staff
    • History
    • Newsletter Archive
  • Members
    • Member Registration
    • Forgot Password

Voice Preservation

Making Our Voices Heard

Speech is a key part of a person’s identity. Voice matters to personal identity and expression, and connection with family and friends. The majority of people living with ALS/MND are eventually robbed of this fundamental part of their humanity.

This can be overcome using voice preservation technologies, but our research shows this is not equitably accessible. The Alliance seeks to provide universal access to technology to improve the quality of life of people living with ALS/MND. The ideal for every individual living with ALS/MND worldwide is to have the right to access voice preservation upon diagnosis.

The Voice Preservation Project

The Alliance, through a collaboration between Hospital Universitario Nacional de Colombia (HUN) and the Asociación Colombiana de ELA (ACELA), has launched a pilot project to deliver voice preservation technology to people living with ALS/MND in Colombia. This will serve as the basis on which future plans will be made on how best to scale to reach more people around the world.

If you would like to join us in expanding our reach to more people, please donate. We deeply appreciate your support.

Watch this video to find out more from the Alliance and its Information Technology Advisory Council (ITAC).

https://www.als-mnd.org/wp-content/uploads/2023/06/Voice-Preservation-ITAC-Intro.mp4

Watch this video to hear from Orlando Ruiz, founder of ACELA and a person living with ALS/MND, as he emphasizes the devastation of losing your voice. He goes on to explain the potential of voice banking technology to preserve dignity, autonomy and identity, and ensure no one loses their voice to ALS/MND.

 

Keep Up To Date

This project is in development and more details and information are coming soon! If you are interested in learning more, sign up to get periodic updates as the work progresses.

Subscribe

* indicates required
 
 

 

Disclaimer: Voice preservation is not designed, intended or made available for diagnosis, treatment or prevention of diseases or for use as a medical device. It is also not designed or intended to replace or be a substitute for professional medical advice, diagnosis, treatment or judgment.

Primary Sidebar

  • Kirsty Gerlach, New Zealand

    Kirsty Gerlach, New Zealand

  • Emilienne Verhaegen, Belgium

    Emilienne Verhaegen, Belgium

  • Roy Taylor, Ireland

    Roy Taylor, Ireland
    roy

  • Ian Roberts, Australia

    Ian Roberts, Australia

  • Irene McCaughey, Australia

    Irene McCaughey, Australia

  • Cassio Fernando da Silva, Brazil

    Cassio Fernando da Silva, Brazil

  • Murat Morali, Turkey

    Murat Morali, Turkey

  • Bayley, Australia

    Bayley, Australia

  • Jette Odgaard Villemoes, Denmark

    Jette Odgaard Villemoes, Denmark

  • Elkin Gaviria, Colombia

    Elkin Gaviria, Colombia

  • Ailsa Malcolm-Hutton, UK

    Ailsa Malcolm-Hutton, UK

  • Alfredo Santos, Colombia

    Alfredo Santos, Colombia

  • Inta Grubb, Australia

    Inta Grubb, Australia

  • Steven Gallagher, Canada

    Steven Gallagher, Canada

  • Sally Pauls, USA

    Sally Pauls, USA

  • Ali Var, Turkey

    Ali Var, Turkey

  • Sanjay Kumar Srivastava, India

    Sanjay Kumar Srivastava, India

  • Lee Millard, England

    Lee Millard, England

  • Den Haag, Netherlands

    Den Haag, Netherlands

  • Chen Yin Xue, Taiwan

    Chen Yin Xue, Taiwan

  • Liam Dwyer, England

    Liam Dwyer, England

  • Brigitte Wernli, Switzerland

    Brigitte Wernli, Switzerland

  • Erwin Coppejans, Belgium

    Erwin Coppejans, Belgium

  • Liong Ting Ngu, Malaysia

    Liong Ting Ngu, Malaysia

  • Greg Heydet, USA

    Greg Heydet, USA

  • Brian Lovell, Australia

    Brian Lovell, Australia

  • Alejandro Aquino, Argentina

    Alejandro Aquino, Argentina

  • Paul Launer, USA

    Paul Launer, USA

  • JP

    JP

  • Glen Victor Peters, Australia

    Glen Victor Peters, Australia

  • Glen Elison, USA

    Glen Elison, USA

  • Oliver Juenke, Germany

    Oliver Juenke, Germany

  • Jason Goodman, USA

    Jason Goodman, USA

  • Yessenia Hernandez Mendoza, Mexico

    Yessenia Hernandez Mendoza, Mexico

  • Susan Keldani, USA

    Susan Keldani, USA

  • Carlos Alberto Arango, Colombia

    Carlos Alberto Arango, Colombia

  • Susan Anderson, USA

    Susan Anderson, USA

  • Phil Rossall, UK

    Phil Rossall, UK

  • Karl Hughes, Ireland

    Karl Hughes, Ireland

  • Carlos Gomez Matallanas, Spain

    Carlos Gomez Matallanas, Spain

  • Duncan Bayly, Australia

    Duncan Bayly, Australia

  • David Bishop, UK

    David Bishop, UK

  • Manuel Arn, Switzerland

    Manuel Arn, Switzerland

  • Cath Muir, UK

    Cath Muir, UK
    Cath

  • Philip Brindle, England

    Philip Brindle, England

  • H. Todd Kelly, USA

    H. Todd Kelly, USA

  • Jack Buzby, USA

    Jack Buzby, USA

  • Danny Reviers, Belgium

    Danny Reviers, Belgium
    DannyReviers

  • Chun Ju Xiao, China

    Chun Ju Xiao, China

  • Alex, Argentina

    Alex, Argentina

Learn more about the March of Faces

Footer

Stay connected to the global ALS/MND community.

Subscribe to receive our newsletter and updates on how to get involved across the Alliance network.

 
This field is for validation purposes and should be left unchanged.
  • Email
  • Facebook
  • LinkedIn
  • Twitter
  • YouTube
Return to top of page

Contact | Disclaimer | Privacy Notice & Cookies | Sitemap

Copyright © 2026 The International Alliance of ALS/MND Associations. All rights reserved.


Registered in England: Charity Number 1079504 · Site built by graphics.coop · Powered by WordPress · Members' login